Erythropoietin may improve anemia in patients with autoimmune hemolytic anemia associated with reticulocytopenia. （開啟新視窗）

Arbach O, Funck R, Seibt F, Salama A.

出處‎: Transfus Med Hemother 2012;39(3):221-3.

檢索‎: PubMed 22851939

DOI碼‎: 10.1159/000339260

https://www.ncbi.nlm.nih.gov/pubmed/22851939 （開啟新視窗）

The changing spectrum of drug-induced immune hemolytic anemia. （開啟新視窗）

Arndt PA, Garratty G.

出處‎: Semin Hematol 2005;42(3):137-44.

檢索‎: PubMed 16041663

https://www.ncbi.nlm.nih.gov/pubmed/16041663 （開啟新視窗）

Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies. （開啟新視窗）

Barcellini W, Zaja F, Zaninoni A, Imperiali FG, Battista ML, Di Bona E, Fattizzo B, Consonni D, Cortelezzi A, Fanin R, Zanella A.

出處‎: Blood 2012;119(16):3691-7.

檢索‎: PubMed 22267606

DOI碼‎: 10.1182/blood-2011-06-363556

https://www.ncbi.nlm.nih.gov/pubmed/22267606 （開啟新視窗）

Autoimmune hemolytic anemia. （開啟新視窗）

Gehrs BC, Friedberg RC.

出處‎: Am J Hematol 2002;69(4):258-71.

檢索‎: PubMed 11921020

https://www.ncbi.nlm.nih.gov/pubmed/11921020 （開啟新視窗）

Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias. （開啟新視窗）

Gómez-Almaguer D, Solano-Genesta M, Tarín-Arzaga L, Herrera-Garza JL, Cantú-Rodríguez OG, Gutiérrez-Aguirre CH, Jaime-Pérez JC.

出處‎: Blood 2010;116(23):4783-5.

檢索‎: PubMed 20841509

DOI碼‎: 10.1182/blood-2010-06-291831

https://www.ncbi.nlm.nih.gov/pubmed/20841509 （開啟新視窗）

A case of late-onset systemic lupus erythematosus with severe anemia. （開啟新視窗）

Matsumoto M, Kaieda S, Honda S, Ida H, Hoshino T, Fukuda T.

出處‎: Kurume Med J 2013;60(1):25-8.

檢索‎: PubMed 23925156

https://www.ncbi.nlm.nih.gov/pubmed/23925156 （開啟新視窗）

High-dose cyclophosphamide for refractory autoimmune hemolytic anemia. （開啟新視窗）

Moyo VM, Smith D, Brodsky I, Crilley P, Jones RJ, Brodsky RA.

出處‎: Blood 2002;100(2):704-6.

檢索‎: PubMed 12091370

DOI碼‎: 10.1182/blood-2002-01-0087

https://www.ncbi.nlm.nih.gov/pubmed/12091370 （開啟新視窗）

Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia. （開啟新視窗）

Zecca M, De Stefano P, Nobili B, Locatelli F.

出處‎: Blood 2001;97(12):3995-7.

檢索‎: PubMed 11389047

https://www.ncbi.nlm.nih.gov/pubmed/11389047 （開啟新視窗）

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. （開啟新視窗）

Zecca M, Nobili B, Ramenghi U, Perrotta S, Amendola G, Rosito P, Jankovic M, Pierani P, De Stefano P, Bonora MR, Locatelli F.

出處‎: Blood 2003;101(10):3857-61.

檢索‎: PubMed 12531800

DOI碼‎: 10.1182/blood-2002-11-3547

https://www.ncbi.nlm.nih.gov/pubmed/12531800 （開啟新視窗）